1. Home
  2. GKOS vs VVV Comparison

GKOS vs VVV Comparison

Compare GKOS & VVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • VVV
  • Stock Information
  • Founded
  • GKOS 1998
  • VVV 1866
  • Country
  • GKOS United States
  • VVV United States
  • Employees
  • GKOS 995
  • VVV N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • VVV Major Chemicals
  • Sector
  • GKOS Health Care
  • VVV Industrials
  • Exchange
  • GKOS Nasdaq
  • VVV Nasdaq
  • Market Cap
  • GKOS 5.1B
  • VVV 4.7B
  • IPO Year
  • GKOS 2015
  • VVV 2016
  • Fundamental
  • Price
  • GKOS $90.26
  • VVV $33.48
  • Analyst Decision
  • GKOS Strong Buy
  • VVV Buy
  • Analyst Count
  • GKOS 13
  • VVV 11
  • Target Price
  • GKOS $155.00
  • VVV $44.00
  • AVG Volume (30 Days)
  • GKOS 1.0M
  • VVV 1.8M
  • Earning Date
  • GKOS 04-30-2025
  • VVV 05-07-2025
  • Dividend Yield
  • GKOS N/A
  • VVV N/A
  • EPS Growth
  • GKOS N/A
  • VVV N/A
  • EPS
  • GKOS N/A
  • VVV 2.08
  • Revenue
  • GKOS $383,481,000.00
  • VVV $1,659,900,000.00
  • Revenue This Year
  • GKOS $27.84
  • VVV $9.14
  • Revenue Next Year
  • GKOS $27.99
  • VVV $14.43
  • P/E Ratio
  • GKOS N/A
  • VVV $15.93
  • Revenue Growth
  • GKOS 21.85
  • VVV 11.85
  • 52 Week Low
  • GKOS $77.91
  • VVV $31.02
  • 52 Week High
  • GKOS $163.71
  • VVV $48.27
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 41.57
  • VVV 44.21
  • Support Level
  • GKOS $86.16
  • VVV $32.88
  • Resistance Level
  • GKOS $94.55
  • VVV $34.73
  • Average True Range (ATR)
  • GKOS 6.54
  • VVV 1.45
  • MACD
  • GKOS 1.11
  • VVV 0.02
  • Stochastic Oscillator
  • GKOS 54.51
  • VVV 50.98

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About VVV Valvoline Inc.

Valvoline Inc produces, markets, and sells automotive maintenance products, particularly lubricants, to retail outlets installers, and customers. The company offers various products such as engine oil, heavy-duty engine oil, motorcycle oil, grease and brake fluid, and others. Geographically, the majority of the revenue is generated from the United States of America.

Share on Social Networks: